Development and characterization of [123I] iodotiagabine for in-vivo GABA-transporter imaging

O Schijns, M van Kroonenburgh, FJ Beekman, J Verbeek, J Herscheid, K Rijkers, V Visser-VandeWalle, G Hoogland

Research output: Contribution to journal › Article › Scientific › peer-review

3 Citations (Scopus)

Original language	English
Pages (from-to)	175-179
Number of pages	5
Journal	Nuclear Medicine Communications
Volume	34
Issue number	2
DOIs	https://doi.org/10.1097/MNM.0b013e32835bbbd7
Publication status	Published - 2013

Access to Document

@article{5562a695bcb445a88b519568f957f811,

title = "Development and characterization of [123I] iodotiagabine for in-vivo GABA-transporter imaging",

author = "O Schijns and {van Kroonenburgh}, M and FJ Beekman and J Verbeek and J Herscheid and K Rijkers and V Visser-VandeWalle and G Hoogland",

year = "2013",

doi = "10.1097/MNM.0b013e32835bbbd7",

language = "English",

volume = "34",

pages = "175--179",

journal = "Nuclear Medicine Communications",

issn = "0143-3636",

publisher = "Lippincott Williams and Wilkins",

number = "2",

}

TY - JOUR

T1 - Development and characterization of [123I] iodotiagabine for in-vivo GABA-transporter imaging

AU - Schijns, O

AU - van Kroonenburgh, M

AU - Beekman, FJ

AU - Verbeek, J

AU - Herscheid, J

AU - Rijkers, K

AU - Visser-VandeWalle, V

AU - Hoogland, G

PY - 2013

Y1 - 2013

U2 - 10.1097/MNM.0b013e32835bbbd7

DO - 10.1097/MNM.0b013e32835bbbd7

M3 - Article

SN - 0143-3636

VL - 34

SP - 175

EP - 179

JO - Nuclear Medicine Communications

JF - Nuclear Medicine Communications

IS - 2

ER -